Hipra will carry out a so-called Phase II trial, on the volunteers

Hipra will carry out a so-called Phase II trial, on the volunteers.

15-11-2021Javier Cebollada

Spain's health regulator has authorised Spanish pharmaceutical group Hipra to test the COVID-19 vaccine it is developing on more than 1,000 volunteers, Prime Minister Pedro Sanchez said on Monday.

Hipra will carry out a so-called Phase II trial - the second stage of a three-round trial process, on the volunteers, Sanchez said.

Comments

To be able to write a comment, you have to be registered and be logged in.

* Mandatory fields

Currently there are no comments.